Carnosine Alleviates Knee Osteoarthritis And Promotes Synoviocyte Protection Via Activating The Nrf2 HO 1 Signaling Pathway An In Vivo And In Vitro Study (1)

This study investigated whether carnosine, a naturally occurring compound found in muscle and brain tissue, could help treat knee osteoarthritis. Researchers used laboratory rats with surgically induced knee osteoarthritis to test carnosine's effects on joint pain, inflammation, and tissue damage. They also conducted cellular studies to understand how carnosine works at the molecular level.

The results were promising across multiple measures. Rats treated with carnosine showed significant pain reduction in standard mobility tests. Blood tests and joint fluid analysis revealed lower levels of inflammatory proteins that typically drive osteoarthritis progression. Most importantly, microscopic examination of knee tissues showed that carnosine treatment preserved cartilage structure and reduced the depth of joint damage compared to untreated animals.

The researchers discovered that carnosine works by activating a cellular protection system called the Nrf2/HO-1 pathway, which helps cells defend against oxidative stress and inflammation. This pathway is crucial for maintaining healthy joints as we age. Carnosine also reduced the production of enzymes that break down cartilage, while simultaneously decreasing inflammatory markers like COX-2.

From a metabolic health perspective, this research is significant because osteoarthritis often limits physical activity, which can negatively impact overall metabolism and longevity. By potentially preserving joint function, carnosine supplementation might help maintain an active lifestyle crucial for healthy aging. While these are animal studies, the findings suggest carnosine could be explored as a natural approach to joint health in clinical practice, particularly for patients seeking alternatives or additions to conventional osteoarthritis treatments.